 Cheng Hu
Concepts (282)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypoxia-Inducible Factor 1, alpha Subunit | 15 | 2023 | 300 | 2.550 |
Why?
| | Hypertension, Pulmonary | 15 | 2025 | 1977 | 2.220 |
Why?
| | Transcriptional Activation | 10 | 2018 | 372 | 1.470 |
Why?
| | Hypoxia | 13 | 2024 | 1208 | 1.130 |
Why?
| | Upstream Stimulatory Factors | 3 | 2013 | 7 | 0.800 |
Why?
| | Gene Expression Regulation | 11 | 2021 | 2625 | 0.770 |
Why?
| | Cell Hypoxia | 10 | 2014 | 249 | 0.730 |
Why?
| | STAT3 Transcription Factor | 2 | 2013 | 215 | 0.680 |
Why?
| | Fibroblasts | 8 | 2025 | 1039 | 0.620 |
Why?
| | Transcription Factors | 6 | 2013 | 1747 | 0.620 |
Why?
| | Disease Susceptibility | 1 | 2021 | 347 | 0.580 |
Why?
| | Myocytes, Smooth Muscle | 3 | 2020 | 274 | 0.580 |
Why?
| | Pulmonary Artery | 4 | 2024 | 1132 | 0.580 |
Why?
| | Muscle, Smooth, Vascular | 2 | 2020 | 450 | 0.530 |
Why?
| | MicroRNAs | 2 | 2021 | 694 | 0.500 |
Why?
| | Signal Transduction | 8 | 2024 | 5272 | 0.490 |
Why?
| | Cells, Cultured | 10 | 2025 | 4169 | 0.480 |
Why?
| | RNA-Binding Proteins | 1 | 2020 | 451 | 0.470 |
Why?
| | RNA Splicing | 2 | 2014 | 285 | 0.450 |
Why?
| | Endothelial Cells | 7 | 2024 | 886 | 0.410 |
Why?
| | Animals | 34 | 2025 | 38410 | 0.410 |
Why?
| | Adrenomedullin | 1 | 2014 | 5 | 0.410 |
Why?
| | Hypoxia-Inducible Factor 1 | 2 | 2013 | 69 | 0.390 |
Why?
| | Alternative Splicing | 2 | 2017 | 248 | 0.380 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2013 | 109 | 0.360 |
Why?
| | DNA Helicases | 1 | 2013 | 137 | 0.350 |
Why?
| | Vascular Remodeling | 3 | 2024 | 209 | 0.330 |
Why?
| | Trans-Activators | 3 | 2007 | 398 | 0.320 |
Why?
| | Nuclear Proteins | 3 | 2013 | 745 | 0.310 |
Why?
| | Respirovirus | 2 | 2000 | 6 | 0.310 |
Why?
| | Promoter Regions, Genetic | 8 | 2013 | 1253 | 0.290 |
Why?
| | Cell Proliferation | 7 | 2020 | 2529 | 0.290 |
Why?
| | Mice | 22 | 2024 | 18491 | 0.280 |
Why?
| | Erythropoietin | 4 | 2014 | 100 | 0.270 |
Why?
| | Phosphoproteins | 2 | 2000 | 337 | 0.260 |
Why?
| | Cattle | 7 | 2025 | 948 | 0.250 |
Why?
| | Viral Proteins | 2 | 2000 | 353 | 0.250 |
Why?
| | Mice, Knockout | 8 | 2019 | 3153 | 0.250 |
Why?
| | Cell Line, Tumor | 6 | 2014 | 3565 | 0.250 |
Why?
| | Transfection | 4 | 2014 | 930 | 0.240 |
Why?
| | Intercellular Signaling Peptides and Proteins | 2 | 2023 | 376 | 0.230 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2013 | 980 | 0.210 |
Why?
| | Stem Cells | 2 | 2006 | 630 | 0.210 |
Why?
| | Phenotype | 4 | 2023 | 3216 | 0.210 |
Why?
| | Complement System Proteins | 2 | 2025 | 320 | 0.210 |
Why?
| | Cell Line | 7 | 2013 | 2832 | 0.190 |
Why?
| | Humans | 30 | 2025 | 147293 | 0.190 |
Why?
| | Hypertrophy, Right Ventricular | 2 | 2023 | 152 | 0.190 |
Why?
| | Sirtuin 3 | 1 | 2023 | 60 | 0.190 |
Why?
| | Cell Survival | 3 | 2014 | 1111 | 0.190 |
Why?
| | Transcription, Genetic | 4 | 2021 | 1456 | 0.180 |
Why?
| | Gene Knockdown Techniques | 2 | 2014 | 334 | 0.180 |
Why?
| | Histone Deacetylase Inhibitors | 2 | 2021 | 219 | 0.180 |
Why?
| | Proto-Oncogene Proteins c-rel | 1 | 2001 | 7 | 0.180 |
Why?
| | RNA, Messenger | 6 | 2020 | 2812 | 0.170 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 2021 | 93 | 0.160 |
Why?
| | HEK293 Cells | 2 | 2013 | 745 | 0.160 |
Why?
| | Receptors, Notch | 2 | 2014 | 91 | 0.160 |
Why?
| | Cellular Microenvironment | 1 | 2021 | 94 | 0.160 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2023 | 248 | 0.150 |
Why?
| | Macrophage Activation | 1 | 2021 | 181 | 0.150 |
Why?
| | Respirovirus Infections | 1 | 1999 | 14 | 0.150 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2020 | 90 | 0.150 |
Why?
| | Histone Deacetylases | 1 | 2021 | 208 | 0.150 |
Why?
| | RNA Polymerase II | 2 | 2013 | 350 | 0.150 |
Why?
| | Glucosephosphate Dehydrogenase | 1 | 2020 | 70 | 0.150 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2014 | 1457 | 0.140 |
Why?
| | Culture Media, Conditioned | 3 | 2023 | 112 | 0.140 |
Why?
| | Proto-Oncogene Proteins | 1 | 2001 | 627 | 0.130 |
Why?
| | Protein Binding | 4 | 2014 | 2249 | 0.130 |
Why?
| | Macrophages, Alveolar | 1 | 2021 | 377 | 0.130 |
Why?
| | Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2017 | 18 | 0.130 |
Why?
| | Polypyrimidine Tract-Binding Protein | 1 | 2017 | 16 | 0.130 |
Why?
| | Pyruvate Kinase | 1 | 2017 | 29 | 0.130 |
Why?
| | Interferon Type I | 2 | 1996 | 148 | 0.130 |
Why?
| | DNA-Binding Proteins | 2 | 2002 | 1488 | 0.130 |
Why?
| | Mice, Inbred C57BL | 4 | 2023 | 6041 | 0.120 |
Why?
| | Chromatin | 1 | 2021 | 561 | 0.120 |
Why?
| | Virus Replication | 1 | 1999 | 521 | 0.120 |
Why?
| | Disease Models, Animal | 3 | 2025 | 4604 | 0.120 |
Why?
| | Glycolysis | 3 | 2025 | 341 | 0.120 |
Why?
| | Embryonic Stem Cells | 2 | 2007 | 124 | 0.120 |
Why?
| | B-Lymphocytes | 1 | 2001 | 878 | 0.120 |
Why?
| | Response Elements | 2 | 2014 | 86 | 0.110 |
Why?
| | Lung Neoplasms | 2 | 2023 | 2679 | 0.110 |
Why?
| | RNA Interference | 2 | 2017 | 477 | 0.110 |
Why?
| | Gene Expression | 3 | 2020 | 1481 | 0.110 |
Why?
| | Histones | 1 | 2021 | 672 | 0.110 |
Why?
| | Binding Sites | 2 | 2013 | 1319 | 0.110 |
Why?
| | Cytokines | 1 | 2023 | 2086 | 0.110 |
Why?
| | DNA Methylation | 1 | 2020 | 722 | 0.110 |
Why?
| | Interferon-beta | 1 | 1995 | 92 | 0.110 |
Why?
| | Rats, Sprague-Dawley | 1 | 2019 | 2542 | 0.100 |
Why?
| | Amyloid Precursor Protein Secretases | 1 | 2014 | 78 | 0.100 |
Why?
| | 5' Untranslated Regions | 1 | 2014 | 60 | 0.100 |
Why?
| | Up-Regulation | 3 | 2020 | 848 | 0.100 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 3 | 1 | 2013 | 4 | 0.100 |
Why?
| | Carbonic Anhydrase IX | 1 | 2013 | 4 | 0.100 |
Why?
| | Angiopoietins | 1 | 2013 | 12 | 0.100 |
Why?
| | Carbonic Anhydrases | 1 | 2013 | 12 | 0.100 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 1195 | 0.100 |
Why?
| | Interferon-alpha | 1 | 1995 | 201 | 0.100 |
Why?
| | Cobalt | 1 | 2013 | 50 | 0.100 |
Why?
| | Epigenesis, Genetic | 1 | 2018 | 708 | 0.100 |
Why?
| | Rats | 2 | 2019 | 5613 | 0.100 |
Why?
| | Kupffer Cells | 1 | 2013 | 52 | 0.100 |
Why?
| | Cell Growth Processes | 1 | 2013 | 48 | 0.100 |
Why?
| | Liver Regeneration | 1 | 2013 | 46 | 0.100 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2014 | 105 | 0.100 |
Why?
| | Protein Interaction Maps | 1 | 2013 | 52 | 0.100 |
Why?
| | Mutation | 4 | 2023 | 4130 | 0.090 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2006 | 751 | 0.090 |
Why?
| | Exons | 1 | 2014 | 365 | 0.090 |
Why?
| | Breast Neoplasms | 3 | 2014 | 2420 | 0.090 |
Why?
| | Genes, Reporter | 1 | 2013 | 278 | 0.090 |
Why?
| | CREB-Binding Protein | 1 | 2012 | 34 | 0.090 |
Why?
| | p300-CBP Transcription Factors | 1 | 2012 | 25 | 0.090 |
Why?
| | Cellular Reprogramming | 2 | 2025 | 98 | 0.090 |
Why?
| | Cell Transformation, Neoplastic | 2 | 2012 | 340 | 0.090 |
Why?
| | Cell Movement | 2 | 2013 | 966 | 0.090 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2013 | 138 | 0.090 |
Why?
| | Antigens, Neoplasm | 1 | 2013 | 273 | 0.090 |
Why?
| | Oxidative Stress | 1 | 2018 | 1368 | 0.090 |
Why?
| | Plasmids | 1 | 2012 | 373 | 0.080 |
Why?
| | Carcinogenesis | 1 | 2013 | 230 | 0.080 |
Why?
| | Blotting, Western | 1 | 2013 | 1186 | 0.080 |
Why?
| | Carcinoma, Renal Cell | 1 | 2013 | 233 | 0.080 |
Why?
| | Chromatin Immunoprecipitation | 2 | 2007 | 139 | 0.080 |
Why?
| | RNA, Small Interfering | 1 | 2012 | 643 | 0.080 |
Why?
| | Oxygen | 2 | 2014 | 998 | 0.080 |
Why?
| | Hypertension | 1 | 2018 | 1280 | 0.070 |
Why?
| | Biomarkers | 1 | 2021 | 4351 | 0.070 |
Why?
| | Macrophages | 2 | 2017 | 1529 | 0.070 |
Why?
| | Heart Failure | 1 | 2023 | 2334 | 0.070 |
Why?
| | Antiviral Agents | 1 | 1995 | 776 | 0.070 |
Why?
| | Tumor Microenvironment | 1 | 2013 | 748 | 0.070 |
Why?
| | Kidney Neoplasms | 1 | 2013 | 421 | 0.070 |
Why?
| | Lung | 4 | 2024 | 4141 | 0.070 |
Why?
| | Inflammation | 3 | 2025 | 2920 | 0.070 |
Why?
| | Liver Neoplasms | 1 | 2013 | 787 | 0.060 |
Why?
| | Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2006 | 19 | 0.060 |
Why?
| | Octamer Transcription Factor-3 | 1 | 2006 | 19 | 0.060 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2007 | 169 | 0.060 |
Why?
| | Phosphorylation | 2 | 2000 | 1721 | 0.060 |
Why?
| | Anemia | 1 | 2007 | 192 | 0.060 |
Why?
| | Embryonic Development | 1 | 2006 | 125 | 0.050 |
Why?
| | Teratoma | 1 | 2006 | 124 | 0.050 |
Why?
| | Colonic Neoplasms | 1 | 2007 | 258 | 0.050 |
Why?
| | Liver | 1 | 2013 | 1916 | 0.050 |
Why?
| | Complement C3 | 1 | 2025 | 188 | 0.050 |
Why?
| | Allyl Compounds | 1 | 2023 | 25 | 0.050 |
Why?
| | Genetic Therapy | 2 | 1996 | 317 | 0.050 |
Why?
| | Pericytes | 1 | 2024 | 42 | 0.050 |
Why?
| | Mice, Nude | 4 | 2014 | 680 | 0.050 |
Why?
| | Down-Regulation | 2 | 2006 | 618 | 0.050 |
Why?
| | Biphenyl Compounds | 1 | 2023 | 67 | 0.050 |
Why?
| | Peptidyl-Dipeptidase A | 1 | 2023 | 57 | 0.050 |
Why?
| | Cricetinae | 3 | 2006 | 305 | 0.050 |
Why?
| | DNA, Complementary | 1 | 2003 | 273 | 0.050 |
Why?
| | NAD | 1 | 2023 | 79 | 0.050 |
Why?
| | Repressor Proteins | 1 | 2006 | 429 | 0.050 |
Why?
| | Female | 7 | 2020 | 80076 | 0.050 |
Why?
| | Phenols | 1 | 2023 | 106 | 0.050 |
Why?
| | Tumor Cells, Cultured | 3 | 1999 | 891 | 0.050 |
Why?
| | Interleukin-4 | 1 | 2023 | 207 | 0.050 |
Why?
| | Sensitivity and Specificity | 1 | 2007 | 2017 | 0.050 |
Why?
| | Acrylamides | 1 | 2023 | 74 | 0.050 |
Why?
| | Aniline Compounds | 1 | 2023 | 120 | 0.040 |
Why?
| | Mechanotransduction, Cellular | 1 | 2023 | 121 | 0.040 |
Why?
| | Protein Isoforms | 2 | 2017 | 398 | 0.040 |
Why?
| | Adaptive Immunity | 1 | 2023 | 171 | 0.040 |
Why?
| | Interleukin-10 | 1 | 2023 | 311 | 0.040 |
Why?
| | Mitochondrial Proteins | 1 | 2023 | 264 | 0.040 |
Why?
| | CHO Cells | 2 | 2006 | 169 | 0.040 |
Why?
| | Male | 4 | 2025 | 73950 | 0.040 |
Why?
| | T-Lymphocyte Subsets | 1 | 2023 | 421 | 0.040 |
Why?
| | Ventricular Remodeling | 1 | 2023 | 283 | 0.040 |
Why?
| | Transforming Growth Factor beta | 1 | 2023 | 475 | 0.040 |
Why?
| | Ventricular Function, Right | 1 | 2023 | 300 | 0.040 |
Why?
| | Coculture Techniques | 1 | 2021 | 247 | 0.040 |
Why?
| | Cardiovascular System | 1 | 2002 | 139 | 0.040 |
Why?
| | Cytochrome P450 Family 2 | 1 | 2020 | 12 | 0.040 |
Why?
| | Bone Marrow Transplantation | 1 | 2001 | 298 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2001 | 241 | 0.040 |
Why?
| | Bone Marrow Cells | 1 | 2001 | 325 | 0.040 |
Why?
| | Phosphopeptides | 1 | 2000 | 19 | 0.040 |
Why?
| | Base Sequence | 1 | 2003 | 2175 | 0.040 |
Why?
| | HeLa Cells | 2 | 2006 | 633 | 0.040 |
Why?
| | Blotting, Northern | 1 | 1999 | 203 | 0.040 |
Why?
| | Sequence Deletion | 1 | 2000 | 192 | 0.040 |
Why?
| | Mice, Inbred ICR | 1 | 1999 | 113 | 0.040 |
Why?
| | ErbB Receptors | 1 | 2023 | 638 | 0.040 |
Why?
| | Spleen | 1 | 2001 | 509 | 0.040 |
Why?
| | Pyrimidines | 1 | 2023 | 532 | 0.040 |
Why?
| | Point Mutation | 1 | 2000 | 245 | 0.040 |
Why?
| | Neovascularization, Physiologic | 2 | 2013 | 197 | 0.040 |
Why?
| | Indoles | 1 | 2023 | 510 | 0.040 |
Why?
| | Forkhead Box Protein M1 | 1 | 2018 | 11 | 0.040 |
Why?
| | Antagomirs | 1 | 2017 | 12 | 0.030 |
Why?
| | Naphthoquinones | 1 | 2017 | 20 | 0.030 |
Why?
| | Heart Ventricles | 1 | 2023 | 767 | 0.030 |
Why?
| | Genetic Vectors | 2 | 1996 | 335 | 0.030 |
Why?
| | Genome, Viral | 1 | 1999 | 216 | 0.030 |
Why?
| | RNA, Long Noncoding | 1 | 2020 | 173 | 0.030 |
Why?
| | Metabolome | 1 | 2021 | 391 | 0.030 |
Why?
| | Cell Division | 2 | 1996 | 758 | 0.030 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2023 | 889 | 0.030 |
Why?
| | Mitochondria | 1 | 2023 | 1000 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2003 | 1794 | 0.030 |
Why?
| | Adenoviruses, Human | 1 | 1996 | 26 | 0.030 |
Why?
| | Protein Kinase Inhibitors | 1 | 2023 | 984 | 0.030 |
Why?
| | Peptide Fragments | 1 | 2000 | 698 | 0.030 |
Why?
| | Proteomics | 1 | 2023 | 1203 | 0.030 |
Why?
| | RNA, Viral | 1 | 1999 | 695 | 0.030 |
Why?
| | Interleukin-1beta | 1 | 2017 | 394 | 0.030 |
Why?
| | Dependovirus | 1 | 1996 | 78 | 0.030 |
Why?
| | Vero Cells | 1 | 1995 | 83 | 0.030 |
Why?
| | Neoplasms, Experimental | 1 | 1996 | 167 | 0.030 |
Why?
| | Guinea Pigs | 1 | 1995 | 159 | 0.030 |
Why?
| | Interferons | 1 | 1996 | 186 | 0.030 |
Why?
| | Cats | 1 | 1995 | 241 | 0.030 |
Why?
| | Macaca mulatta | 1 | 1995 | 187 | 0.030 |
Why?
| | Transcriptome | 1 | 2021 | 1059 | 0.030 |
Why?
| | Neoplasm Transplantation | 1 | 2014 | 246 | 0.030 |
Why?
| | Phosphoglycerate Kinase | 1 | 2013 | 2 | 0.020 |
Why?
| | Species Specificity | 1 | 1995 | 547 | 0.020 |
Why?
| | Rabbits | 1 | 1995 | 654 | 0.020 |
Why?
| | Amino Acids, Dicarboxylic | 1 | 2013 | 9 | 0.020 |
Why?
| | Deferoxamine | 1 | 2013 | 27 | 0.020 |
Why?
| | Propanolamines | 1 | 2013 | 40 | 0.020 |
Why?
| | Receptors, CCR2 | 1 | 2013 | 39 | 0.020 |
Why?
| | Dogs | 1 | 1995 | 518 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2014 | 762 | 0.020 |
Why?
| | Lung Diseases | 1 | 1999 | 787 | 0.020 |
Why?
| | Pyrrolidines | 1 | 2013 | 126 | 0.020 |
Why?
| | Protein Subunits | 1 | 2013 | 229 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 1995 | 1371 | 0.020 |
Why?
| | Superoxide Dismutase | 1 | 2013 | 308 | 0.020 |
Why?
| | Endothelium, Vascular | 1 | 2017 | 959 | 0.020 |
Why?
| | Acetaminophen | 1 | 2013 | 269 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2013 | 1266 | 0.020 |
Why?
| | Cell Nucleus | 1 | 2013 | 589 | 0.020 |
Why?
| | Melanoma | 1 | 1996 | 774 | 0.020 |
Why?
| | Immunohistochemistry | 2 | 2006 | 1730 | 0.020 |
Why?
| | Protein Inhibitors of Activated STAT | 1 | 2007 | 6 | 0.020 |
Why?
| | Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2007 | 19 | 0.020 |
Why?
| | Sp1 Transcription Factor | 1 | 2007 | 24 | 0.020 |
Why?
| | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2007 | 27 | 0.020 |
Why?
| | COUP Transcription Factor II | 1 | 2006 | 1 | 0.020 |
Why?
| | NIH 3T3 Cells | 1 | 2007 | 145 | 0.020 |
Why?
| | Erythropoiesis | 1 | 2007 | 57 | 0.020 |
Why?
| | Cricetulus | 1 | 2006 | 118 | 0.020 |
Why?
| | Embryo, Mammalian | 1 | 2007 | 234 | 0.010 |
Why?
| | Transforming Growth Factor alpha | 1 | 2006 | 55 | 0.010 |
Why?
| | Feedback | 1 | 2006 | 181 | 0.010 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2007 | 199 | 0.010 |
Why?
| | Calcium-Binding Proteins | 1 | 2006 | 222 | 0.010 |
Why?
| | Arteries | 1 | 2006 | 262 | 0.010 |
Why?
| | Cell Cycle | 1 | 2007 | 600 | 0.010 |
Why?
| | Stress, Physiological | 1 | 2007 | 445 | 0.010 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2006 | 430 | 0.010 |
Why?
| | Models, Genetic | 1 | 2006 | 536 | 0.010 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2006 | 552 | 0.010 |
Why?
| | Alleles | 1 | 2006 | 909 | 0.010 |
Why?
| | Cell Cycle Proteins | 1 | 2006 | 633 | 0.010 |
Why?
| | von Hippel-Lindau Disease | 1 | 2002 | 12 | 0.010 |
Why?
| | Hematopoiesis | 1 | 2002 | 195 | 0.010 |
Why?
| | Models, Biological | 1 | 2006 | 1772 | 0.010 |
Why?
| | Cell Differentiation | 1 | 2006 | 2054 | 0.010 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2002 | 915 | 0.010 |
Why?
| | Mesocricetus | 1 | 1996 | 52 | 0.010 |
Why?
| | Leukemia, Myeloid | 1 | 1996 | 49 | 0.010 |
Why?
| | Luciferases | 1 | 1996 | 155 | 0.010 |
Why?
| | Transplantation, Heterologous | 1 | 1996 | 170 | 0.010 |
Why?
| | Clone Cells | 1 | 1996 | 263 | 0.010 |
Why?
| | Placenta | 1 | 2002 | 793 | 0.010 |
Why?
| | Gene Transfer Techniques | 1 | 1996 | 189 | 0.010 |
Why?
| | Pregnancy | 1 | 2006 | 7274 | 0.010 |
Why?
| | Kinetics | 1 | 1996 | 1569 | 0.010 |
Why?
| | Zinc | 1 | 1996 | 309 | 0.010 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 1996 | 536 | 0.010 |
Why?
| | Kidney | 1 | 1996 | 1511 | 0.000 |
Why?
|
|
Hu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|